跳至主要内容
临床试验/DRKS00024354
DRKS00024354招募中不适用

German SLD-Registry - Characterization of Patients With Steatotic Liver Disease (SLD) in Germany - Phase 1 (Observation of the Natural Course) - SLD-Registry

eberstiftungs-GmbH Deutschland0 个研究点目标入组 10,000 人开始时间: 2021年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • diagnosed SLD based on the following criteria:
  • 1. typical finding of hepatic steatosis (abdominal ultrasound and/or pathological CAP value (latter is optional)
  • 2. Evaluation of NAFLD degree by NAFLD Fibrosis score and/or FIB-4-Index and/or transient elastography
  • 3. Evaluation of metabolic syndrome
  • - credible assessment of alcohol consumption
  • - written informed consent

排除标准

  • - patients with other hepatologic diseases (chronically viral, metabolic, autoimmune origin
  • - patients receiving hepatotoxic medications over a longer period (e.g. methotrexate, amiodarone, longterm NSAR intake)
  • - malignant disease with a life expectancy <12 months
  • - participation in clinical interventional/pivotal studies
  • - inability to provide written informed consent

研究者

发起方
eberstiftungs-GmbH Deutschland

相似试验